Currencies / OTLK
OTLK: Outlook Therapeutics Inc
0.85
USD
0.24
(22.02%)
OTLK exchange rate has changed by -22.02% for today. During the day, the instrument was traded at a low of 0.84 and at a high of 1.07.
Follow Outlook Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
OTLK News
- OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug
- Outlook Therapeutics stock rating downgraded by H.C. Wainwright on FDA rejection
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16%
- Nasdaq Surges 100 Points; Dollar General Earnings Beat Views - CaliberCos (NASDAQ:CWD), Accelerant Holdings (NYSE:ARX)
- FDA Rejects Outlook Therapeutics Eye Drug For Second Time - Outlook Therapeutics (NASDAQ:OTLK)
- US Stocks Mixed; Nvidia Posts Upbeat Earnings - CaliberCos (NASDAQ:CWD), AquaBounty Techs (NASDAQ:AQB)
- US FDA declines to approve Outlook Therapeutics’ drug for eye condition
- Outlook Therapeutics stock falls after FDA rejects wet AMD drug
- Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Beneficient (NASDAQ:BENF), Bollinger Innovations (NASDAQ:BINI)
- Why The Odds Point To A Favorable FDA Decision For Outlook (NASDAQ:OTLK)
- Outlook Therapeutics Reports Q3 Revenue
- Oncobiologics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates
- New Strong Buy Stocks for July 30th
- Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event
- Brookline Capital lowers Outlook Therapeutics stock price target on cash balance
- Rubrik To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday - Broadcom (NASDAQ:AVGO), Aemetis (NASDAQ:AMTX)
- Ascendiant Capital lowers Outlook Therapeutics stock price target to $21
- Outlook Therapeutics launches LYTENAVA in Germany and UK
- Outlook Therapeutics ® Announces Pricing of $13.0 Million Public Offering
- Outlook Therapeutics announces public stock offering
- Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
- Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday - Alnylam Pharmaceuticals (NASDAQ:ALNY), Bath & Body Works (NYSE:BBWI)
Daily Range
0.84
1.07
Year Range
0.79
8.31
- Previous Close
- 1.09
- Open
- 1.04
- Bid
- 0.85
- Ask
- 1.15
- Low
- 0.84
- High
- 1.07
- Volume
- 13.311 K
- Daily Change
- -22.02%
- Month Change
- -56.41%
- 6 Months Change
- -45.51%
- Year Change
- -88.48%
31 August, Sunday